Press releases
- Update - GSK Consumer Healthcare
- GSK and Vir submit Emergency Use Authorization application to FDA for intramuscular administration of sotrovimab for the early treatment of COVID-19
- GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
Tweets from GSK US
-
GSKUS @GSKUS
As we reflect on #MLKday we hope you will take the time to honor and reflect on Dr. King's legacy of bold leadership. Our colleagues shared what #MLKday means to them. What does it mean to you?
about 5 hours ago -
GSKUS @GSKUS
#News for #investors and #media: Today, in partnership with @Vir_Biotech, we’re proud to announce the United States government will purchase additional supply of an investigational monoclonal antibody for the early treatment of #COVID19. Read more here: gsk.to/33kwsYf
about 6 days ago
-
GSKUS @GSKUS
#Investors and #Media Watch Hal Barron, our Chief Scientific Officer and President, R&D, on an @endpts #JPM22 panel tomorrow at 1330 EST / 1030 PST / 1830 GMT discussing key pharma R&D trends for 2022 – register here: gsk.to/3zGP2WC at #JPM22
about 7 days ago
